WestEnd Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305 Hold
2
﹤0.01% 368
2026
Q1
$420 Hold
2
﹤0.01% 323
2025
Q4
$568 Hold
2
﹤0.01% 298
2025
Q3
$617 Sell
2
-1
-33% -$313 ﹤0.01% 283
2025
Q2
$943 Hold
3
﹤0.01% 215
2025
Q1
$788 Buy
3
+2
+200% +$541 ﹤0.01% 231
2024
Q4
$261 Hold
1
﹤0.01% 236
2024
Q3
$233 Hold
1
﹤0.01% 276
2024
Q2
$202 Hold
1
﹤0.01% 267
2024
Q1
$171 Hold
1
﹤0.01% 259
2023
Q4
$217 Hold
1
﹤0.01% 230
2023
Q3
$159 Buy
+1
New +$224 ﹤0.01% 243
2023
Q1
Hold
0
195

Other funds holding PODD

WestEnd Advisors's PODD Position: Q2 2026 in Review

WestEnd Advisors held its Insulet (PODD) position steady in Q2 2026 at 2 shares worth $305. The position accounts for ﹤0.01% of the portfolio, ranked #368.

WestEnd Advisors first reported a position in PODD in Q3 2023 and has held it in 12 quarters since. The position peaked at $943 in Q2 2025. 726 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • WestEnd Advisors held 2 shares of Insulet worth $305 as of Q2 2026.
  • WestEnd Advisors left its Insulet share count unchanged in Q2 2026.
  • Insulet made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #368 holding.
  • WestEnd Advisors first reported a position in Insulet in Q3 2023 and has held it in 12 quarters since.
  • WestEnd Advisors's Insulet position peaked at $943 in Q2 2025.
  • 726 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.